Accelerating Ocular Research
Advancing Sight Network and the Precision Ocular Biobank are the world-class leaders in providing the highest-quality human cells, tissues, and histology slides. We work with top pharmaceuticals, biotechs and academic centers and we can help you complete your next study or build an entire program to grow your impact!
Credentials and Authorization -We've Got You Covered

The Precision Ocular Biobank is built for speed – one of the only eye bank systems in the world that can routinely recover ocular samples in under 6 hours post-mortem. Low death-to-preservation (Post-mortem Interval) is essential for RNA sequencing, retinal studies or detailed morphology analysis. DON'T SETTLE FOR INFERIOR QUALITY.
Uniquely Positioned to Advance Your Research Goals
Unmatched Quality in Ocular Samples
Advancing Sight Network offers unparalleled quality in human cells, cell-models, tissues, and slides.
Our quality begins with rapid recovery and processing of post-mortem tissue to maintain molecular, functional and structural integrity.
Discovery with Comprehensive Resources
We are your One-Stop location for Ocular research.
1) Our extensive collection of On-demand Ocular samples and histology slides are ready to ship.
2) Our Prospective services will recover and process your tissue/cells to meet your exacting criteria.
3) We can build an entire program to meet or accelerate your goals. Whether it's Tissue or Cells, In-House Studies or Partnering on Grants or Co-Development Projects, talk to us to learn how we can help.
Ethical and Sustainable Practices
We are committed to ethical and sustainable practices throughout our operations. We are:
- IRB-Approved
- Follow the International Society of Biological and Environmental Repositories Best Practices,
- Eye Bank of America-accredited
- CTRNet-certified
- Authorization Covers for-profit use and genetic studies.
All to ensure you can conduct your research with integrity and protect your investment, now and in the future.
Global Partners Trust Advancing Sight Network
ASN partners over 40 of the top pharmaceuticals, biotechs and academic center around the world.
- We ship samples to over 30 countries.
- We have long-time academic partnerships with expertise in AMD, Glaucoma and Diabetic Retinopathy , and can build you a comprehensive or custom solution.
- We are a Pharma-approved vendor on Scientist Platform
Services and Products

Human Ocular Samples
We specialize in the procurement, processing and distribution of high-quality human ocular tissues for research. Our network covers four states, which means the increased availability of diverse donors and rare diseases. We adhere to stringent ethical standards and regulatory guidelines to provide tissues that are reliable and ethically sourced. Our team collaborates closely with researchers to understand their specific requirements, ensuring customized solutions and timely delivery.
- On-Demand Sample library featuring over 2,000 fixed and frozen whole globes, vitreous, and aqueous samples.
- Prospective collection of ocular samples to meet your exacting studies.
- Authorization allows for for-profit use and genetic studies
- OCT imaging and gene screening are available
- New Ocular cells
Curcio Collection AMD Slide Sets
Now you can order human post-mortem AMD retinal sections & receive them within a week! No more waiting to get the data you need! Advancing Sight Network together with Dr. Christine A. Curcio have developed standardized sets of cryo-sectioned retinal sections for research.
- Each set contains sections from 15 donor eyes with AMD visible in ex vivo OCT (including drusen, hyperreflective foci and atrophy) and 5 donors with no visible or known retinal disease (controls).
- Each set contains approximately 60 slides and comes with de-identified medical and demographic information on all donors.
- Recipients will receive representative ex vivo OCT scans, images of reference sections (PASH/ H&E), fundus photos and a summary pathology report.
Learn more....

Our Scientific Team
Ophthalmology, Biobanking and Cellular Leadership

Dr. Gregory H Grossman, PhD
Chief Scientific Officer and Scientific Innovation Executive Lead. Dr. Grossman completed his fellowship in ophthalmology at the Cole Eye Institute of the Cleveland Clinic and specializes in Biobanking and Eye Research. He holds certifications in eye banking (CEBT), conducting clinical trials (CCRP), medical affairs (BCMAS), and green laboratory operations (My Green Lab). Dr. Grossman is the president-elect of ISBER, the global society of biobanking and a long-time member of ARVO.

Dr. Deborah Mai, PhD
Cellular and Platform Senior Strategic Lead. Dr. Mai received her PhD in Microbiology from University of Alabama at Birmingham. She heads the new Cellular Research and Therapeutics Division at Advancing Sight Network. She has 10+ years experience in both small and large industry settings performing platform and research services for cell-based drug discovery programs.
Advancing Sight Network (ASN) https://advancingsight.org/ is a registered 501c3 nonprofit organization (Unique Entity ID NJJTPGMNC6S5 EIN: 63-0880135) and an accredited member of the Eye Bank Association of America (EBAA) and its headquarters are registered with the Food and Drug Administration (FDA) as a human tissue facility under FEI # 3001236642. ISNI ID is 0000 0004 0379 7094. Its affiliates operating in Mississippi, Tennessee and Louisiana are also accredited with the EBAA and registered with the FDA as human tissue facilities: Mississippi Lions Eye Bank FEI # 3000215041; MidSouth Eye Bank for Sight Restoration FEI # 1000524671; Southern Eye Bank FEI # 30001215034.
The Precision Ocular Biobank (POB) is a division of ASN specializing in biobanking and distributing ocular tissue for research. The POB is registered with the International Society of Biological and Environmental Repositories (ISBER), Biobanking and BioMolecular Resource Research Infrastructure (BBMRI-ERIC) and is certified through the Canadian Tissue Repository Network (CTRNet). The POB program (Protocol #20- POB-101) has been reviewed and approved (9/04/2020) by an independent Institutional Review Board, Pearl IRB (organization number: 0006471, registration number: 00007772). The POB is a registered, Pharma-approved supplier on Scientist.com. Authorization covers for-profit use as well as genetic studies.